Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Tomas, Berl"'
Autor:
Helbert Rondon-Berrios, Tomas Berl
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
Decreases in the concentration of sodium in plasma constitute hyponatremia, the commonest electrolyte disorder in clinical medicine. It is now well established that its presence conveys an increased mortality risk even when the decrement is mild. In
Externí odkaz:
https://doaj.org/article/4f64d426475442778d4d3c326cc56ab4
Autor:
Tomas Berl, Stuart L. Linas
Publikováno v:
Kidney International. 99:1042-1044
Autor:
Tomas Berl
Publikováno v:
J Am Soc Nephrol
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
Autor:
Tomas Berl, Eberhard Ritz, Yuko Shobu, Miho Shimizu, Giuseppe Remuzzi, Mami Kikuchi, Gerald Schulman, Gerald J. Beck
Publikováno v:
Clinical and Experimental Nephrology
Background Two randomized, double-blind, placebo-controlled trials (EPPIC-1 and EPPIC-2) investigated the efficacy and safety of AST-120, an oral spherical carbon adsorbent, in adults with chronic kidney disease (CKD). While the benefit of adding AST
Autor:
Helbert Rondon-Berrios, Tomas Berl
In the evolutionary process, the successful adaptation of living organisms initially to an aqueous and thereafter to an arid terrestrial environment posed radically different challenges to the maintenance of water balance. Whereas the former required
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26e4c97a60d4a144a634edc66c436ee1
https://doi.org/10.1159/000493233
https://doi.org/10.1159/000493233
Autor:
Tomas Berl, Miho Shimizu, Gerald J. Beck, Akira Kato, Eberhard Ritz, Gerald Schulman, Kiyoshi Arita, Giuseppe Remuzzi
Publikováno v:
Journal of the American Society of Nephrology. 26:1732-1746
Reduced GFR in patients with CKD causes systemic accumulation of uremic toxins, which has been correlated with disease progression and increased morbidity. The orally administered spherical carbon adsorbent AST-120 reduces systemic toxin absorption t
Autor:
Tomas, Berl
Publikováno v:
New England Journal of Medicine. 372:2207-2216
Autor:
Tomas Berl, Helbert Rondon-Berrios
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
Frontiers in Medicine
Frontiers in Medicine
Decreases in the concentration of sodium in plasma constitute hyponatremia, the commonest electrolyte disorder in clinical medicine. It is now well established that its presence conveys an increased mortality risk even when the decrement is mild. In
Autor:
Gail K. Adler, S. Ananth Karumanchi, Rose Ayoob, Juan C. Ayus, George Bakris, Rene Baudrand, Tomas Berl, Wendy B. Bollag, Michael Brines, Alex J. Brown, Ronald B. Brown, John C. Burnett Jr., Robert M. Carey, Daniel F. Catanzaro, Veeraish Chauhan, Yang Chen, Adriana S. Dusso, Carolyn M. Ecelbarger, Carlos M. Ferrario, Peter A. Friedman, Rajesh Garg, Celso E. Gomez-Sanchez, Elise P. Gomez-Sanchez, Koro Gotoh, Carlos M. Isales, Sahir Kalim, Benjamin Ko, Jeffrey A. Kraut, Iain C. Macdougall, John D. Mahan, Laura Meems, Joel Menard, Anastasia S. Mihailidou, David R. Mole, Silvia Monticone, Michael L. Moritz, Glenn T. Nagami, Sagar U. Nigwekar, Shetal H. Padia, Biff F. Palmer, Akhil Parashar, Luminita Pojoga, William E. Rainey, Peter J. Ratcliffe, Mohammed S. Razzaque, Connie M. Rhee, Jose R. Romero, Jeff M. Sands, Lynn E. Schlanger, Robert W. Schrier, Hirotaka Shibata, Domenic A. Sica, Donald C. Simonson, Ajay K. Singh, Karan Sud, Swasti Tiwari, Aaron J. Trask, Jean-Pierre Vilardaga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c12d264256a470e162863aabb894e89
https://doi.org/10.1016/b978-0-12-803247-3.01002-3
https://doi.org/10.1016/b978-0-12-803247-3.01002-3
Autor:
Anna Jovanovich, Tomas Berl
Publikováno v:
Kidney International. 83(4):563-567
The treatment of hyponatremia, an exceedingly common electrolyte disorder, has been a subject of controversy for many years. The advent of vasopressin antagonists (vaptans) has added to the treatment arsenal. This review focuses on why hyponatremia s